Telomir Pharmaceuticals shares owned by UBS Group
Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Telomir Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Telomir Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Telomir Pharmaceuticals by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $88k | 64k | 1.39 |
| 2025-06-30 | $61k | 49k | 1.25 |
| 2025-03-31 | $50k | 15k | 3.23 |
| 2024-12-31 | $103k | 25k | 4.12 |
| 2024-09-30 | $24k | 3.8k | 6.42 |
| 2024-06-30 | $29k | 5.9k | 4.81 |